If I can't remember this morning where I put my car keys last night, it's due to my memory failing me again. Scientists at the Max Planck Institute for Medical Research in Heidelberg have been investigating how memories might be consolidat...

New research identifies an important gene that influences several aspects of nicotine-induced behaviors in the brain. The study, funded by National Institutes of Drug Abuse, was presented at the American College of Neuropsychopharmacology'...

A Queensland Brain Institute (QBI) neuroscientist at the University of Queensland has co-discovered a much-needed approach to treating brain tumours. In research published in Nature, QBI's Professor Brent Reynolds together with colleag...

New research has shown that it might be possible to use taste as an indicator as to whether someone is depressed, and as a way of determining which is the most suitable drug to treat their depression. Research from the University of Bristo...

A study examines the usefulness of diffusion weighted imaging (DWI), a process of scanning and mapping the brain, in establishing the relationship between abnormalities in the cardiovascular system and stroke. This research is helping...

Preliminary research discussed at the American College of Neuropsychopharmacology's Annual Meeting finds that oxytocin, when administered using intravenous fluid and nasal technology may have significant positive effects on adult autis...

Post mortem examination of a third person infected with variant Creutzfeldt-Jakob Disease (vCJD) through blood transfusion has confirmed the presence of the fatal disease. Professor John Collinge of the Medical Research Council (MRC) Prion...

The National Cancer Institute recently awarded The University of Texas M. D. Anderson Cancer Center an $11 million grant to lead the largest genetic study ever conducted on the causes and risk factors of adult and pediatric gliomas, or mal...

Cephalon, Inc. (Nasdaq: CEPH) announced today that the Division of Neurology Products of the U.S. Food and Drug Administration (FDA) has informed the company that it is continuing to evaluate the single case of serious rash reported in a S...

Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced that it had presented preclinical data for its lead compounds, MEM 3454 and MEM 1003, at the American College of Neuropsychopharmacology (ACNP) Annual Meeting, held in Hollywo...